Literature DB >> 9353029

Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis.

M A Skinner1, S Yuan, R Prestidge, D Chuk, J D Watson, P L Tan.   

Abstract

Immune responses to Mycobacterium tuberculosis are analyzed in mice which have been immunized with Mycobacterium vaccae to examine novel ways of altering protective immunity against M. tuberculosis. The spleen cells of mice immunized with M. vaccae proliferate and secrete gamma interferon (IFN-gamma) in response to challenge with live M. tuberculosis in vitro. Immunization with M. vaccae results in the generation of CD8+ T cells which kill syngeneic macrophages infected with M. tuberculosis. These effector cytotoxic T cells (CTL) are detectable in the spleen at 2 weeks after immunization with M. vaccae but cannot be found in splenocytes 3 to 6 weeks postimmunization. However, M. tuberculosis-specific CTL are revealed following restimulation in vitro with heat-killed M. vaccae or M. tuberculosis, consistent with the activation of memory cells. These CD8+ T cells secrete IFN-gamma and enhance the production of interleukin 12 when cocultured with M. tuberculosis-infected macrophages. It is suggested that CD8+ T cells with a cytokine secretion profile of the Tc1 class may themselves maintain the dominance of a Th1-type cytokine response following immunization with M. vaccae. Heat-killed M. vaccae deserves attention as an alternative to attenuated live mycobacterial vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353029      PMCID: PMC175650          DOI: 10.1128/iai.65.11.4525-4530.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Immunotherapy for drug-resistant tuberculosis.

Authors:  A Etemadi; R Farid; J L Stanford
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

2.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

Authors:  I M Orme; E S Miller; A D Roberts; S K Furney; J P Griffin; K M Dobos; D Chi; B Rivoire; P J Brennan
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

Authors:  I M Orme
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

4.  Mycobacteria-reactive Lyt-2+ T cell lines.

Authors:  G De Libero; I Flesch; S H Kaufmann
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

5.  Old plague, new plague, and a treatment for both?

Authors:  J L Stanford; P C Onyebujoh; G A Rook; J M Grange; A Pozniak
Journal:  AIDS       Date:  1993-09       Impact factor: 4.177

6.  Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae.

Authors:  C Abou-Zeid; M P Gares; J Inwald; R Janssen; Y Zhang; D B Young; C Hetzel; J R Lamb; S L Baldwin; I M Orme; V Yeremeev; B V Nikonenko; A S Apt
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.

Authors:  I M Orme
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 9.  Tuberculosis: commentary on a reemergent killer.

Authors:  B R Bloom; C J Murray
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

10.  The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.

Authors:  T H Ottenhoff; B K Ab; J D Van Embden; J E Thole; R Kiessling
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  25 in total

1.  Prevalence and concentration of non-tuberculous mycobacteria in cooling towers by means of quantitative PCR: a prospective study.

Authors:  Bárbara Adrados; Esther Julián; Francesc Codony; Eduard Torrents; Marina Luquin; Jordi Morató
Journal:  Curr Microbiol       Date:  2010-07-18       Impact factor: 2.188

2.  Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Authors:  K Manoutcharian; L I Terrazas; G Gevorkian; G Acero; P Petrossian; M Rodriguez; T Govezensky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice.

Authors:  Laicheng Liu; Ruiling Fu; Xuefeng Yuan; Chunwei Shi; Shuling Wang; Xianyu Lu; Zhao Ma; Xiaoming Zhang; Weiyan Qin; Xionglin Fan
Journal:  Curr Microbiol       Date:  2015-05-21       Impact factor: 2.188

4.  The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein.

Authors:  M A Skinner; R Prestidge; S Yuan; T J Strabala; P L Tan
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

5.  Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.

Authors:  Mingjun Wang; Sheila T Tang; Anette Stryhn; Sune Justesen; Mette V Larsen; Morten H Dziegiel; David M Lewinsohn; Søren Buus; Ole Lund; Mogens H Claesson
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

6.  Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; L Pavon; E H Orozco; J Rangel; G A Rook
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 7.  Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.

Authors:  Chen-Yi Huang; Wen-Yeh Hsieh
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

8.  Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis.

Authors:  Margot A Skinner; Natalie Parlane; Allison McCarthy; Bryce M Buddle
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

9.  Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.

Authors:  Rogelio Hernández-Pando; Diana Aguilar; Hector Orozco; Yuriria Cortez; Laura Rosa Brunet; Graham A Rook
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

10.  Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrug-resistant tuberculosis: A systematic review and meta-analysis.

Authors:  Hong Weng; Jing-Yu Huang; Xiang-Yu Meng; Sheng Li; Gu-Qin Zhang
Journal:  Biomed Rep       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.